Health Care & Life Sciences » Biotechnology | BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp.
Stock Exchange NASDAQ Stock Market
EPS
$2.72
Market Cap
$438.68 M
Shares Outstanding
7.29 M
Public Float
5.34 M

Profile

Address
35 Wilbur Street
Lynbrook New York 11563
United States
Employees -
Website http://www.biospecifics.com
Updated 07/08/2019
BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Financials

View All
Created with Highcharts 5.0.14BioSpecifics Technologies Corp.Net Income. Fiscal year is January-December. All values USD Thousands.5 2855 2854 6464 6469 6179 61711 37211 37211 32811 32820 05320 05320132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14BioSpecifics Technologies Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.14 46714 46714 07714 07722 75022 75026 25126 25127 44327 44332 96132 961201320142015201620172018010k20k30k40k

Mark Wegman
Director
Toby Wegman
Director